In a previous study of Polish patients with breast cancer younger than age 55 years (232 luminal A and 49 CBP), we showed that TDLUs associated with CBP tumors had significantly reduced TDLU involution compared with parenchyma associated with luminal A tumors (ER+ and/or PR+, HER2−) [14]. The gene discussed is ESR1; the disease is breast carcinoma.